Portal de Periódicos da CAPES

Endoscopic treatment of vesicoureteral reflux

2010; Wiley; Volume: 105; Issue: 9 Linguagem: Inglês

10.1111/j.1464-410x.2010.09325.x

1464-410X

Göran Läckgren, Andrew J. Kirsch,

Intestinal Malrotation and Obstruction Disorders

BJU InternationalVolume 105, Issue 9 p. 1332-1347 Endoscopic treatment of vesicoureteral reflux Göran Läckgren, Corresponding Author Göran Läckgren Section of Urology, University Children's Hospital, Uppsala, Sweden, andGöran Läckgren, Section of Urology, University Children's Hospital, Uppsala, Sweden.e-mail: [email protected]Search for more papers by this authorAndrew J. Kirsch, Andrew J. Kirsch Dept.of Pediatric Urology, Childrens Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USASearch for more papers by this author Göran Läckgren, Corresponding Author Göran Läckgren Section of Urology, University Children's Hospital, Uppsala, Sweden, andGöran Läckgren, Section of Urology, University Children's Hospital, Uppsala, Sweden.e-mail: [email protected]Search for more papers by this authorAndrew J. Kirsch, Andrew J. Kirsch Dept.of Pediatric Urology, Childrens Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USASearch for more papers by this author First published: 09 April 2010 https://doi.org/10.1111/j.1464-410X.2010.09325.xCitations: 29 ILLUSTRATIONS by STEPHAN SPITZER, http://www.spitzer-illustration.com Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Hodson E, Wheeler D, Vimalchandra D et al. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev 2007; CD001532 2 Swerkersson S, Jodal U, Sixt R, Stokland E, Hansson S. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children. J Urol 2007; 178: 647– 51 3 Martinell J, Claesson I, Lidin-Janson G et al. Urinary infection, reflux and renal scarring in females continuously followed for 13–38 years. Pediatr Nephrol 1995; 9: 131– 6 4 Faust WC, Pohl HG. Role of prophylaxis in vesicoureteral reflux. Curr Opin Urol 2007; 17: 252– 6 5 Koyle MA, Clement M, Cooper C et al. A critical appraisal of antibiotic prophylaxis and endoscopic injection for vesicoureteral reflux. Issues Urol 2006; 18: 123– 30 6 Elmore JM, Kirsch AJ, Heiss EA, Gilchrist A, Scherz HC. Incidence of UTI in children following successful ureteral reimplantation versus endoscopic Deflux implantation. J Urol 2008; 179: 2364– 7 7 Cerwinka W, Scherz H, Kirsch A. Endoscopic Treatment of Vesicoureteral Reflux with Dextranomer/Hyaluronic Acid in Children. Adv Urol 2008; 2008: Article ID 513854 8 Matouschek E. Die Behandlung des vesikorenalen Refluxes durch transurethrale Einspritzung von Teflon Paste. Urologe A 1981; 20: 263– 4 9 O'Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J 1984; 289: 7– 9 10 Stenberg A, Läckgren G. A new bioimplant, Deflux® System for the treatment of vesicoureteral reflux. Experimental and clinical results. J Urol 1995; 154: 800– 3 11 Stenberg ÅM, Sundin A, Larsson BS et al. Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol 1997; 158: 1937– 41 12 Stenberg ÅM, Larsson E, Lindholm A et al. Injectable dextranomer-based implant: histopathology, volume changes and DNA analysis. Scand J Urol Nephrol 1999; 33: 355– 61 13 Routh JC, Ashley RA, Sebo TJ et al. Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral reflux. J Urol 2007; 178: 1707– 10 14 Stenberg A, Larsson E, Läckgren G. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 2003; 169: 1109– 13 15 McMann L, Scherz HC, Kirsch AJ. Long term preservation of dextranomer/hyaluronic acid copolymer implants after endoscopic treatment of vesicoureteral reflux in children: a sonographic analysis. J Urol 2007; 2007: 316– 20 16 Stenberg A, Läckgren G. Treatment of vesicoureteral reflux in children using stabilized non-animal hyaluronic acid/dextranomer gel (NASHA/DX): a long-term observational study. J Pediatr Urol 2007; 3: 80– 5 17 Kirsch AJ, Perez-Brayfield M, Scherz H. Minimally invasive treatment of vesicoureteric reflux with endoscopic injection of Dx/Ha acid co-polymer: the Children's Hospitals of Atlanta experience. J Urol 2003; 170: 211– 5 18 Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 2004; 171: 2413– 6 19 Cerwinka W, Scherz HC, Kirsch AJ. The dynamic hydrodistention classification of the ureter and the double HIT technique. Arch Esp Urol 2008; 61: 8 20 Kirsch AJ, Kaye JD, Cerwinka WH et al. Hydrodistention of the ureteral orifice: a novel grading system with high reproducibility and clinical correlation in children with vesicoureteral reflux. J Urol 2009; 182: 1688– 92 21 Läckgren G, Wåhlin N, Sköldenberg E et al. Long-term follow-up of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2001; 166: 1887– 92 22 Puri P, Chertin B, Velayudham M et al. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 2003; 170: 1541– 4 23 Yu RN, Roth DR. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon. Pediatrics 2006; 118: 698– 703 24 Läckgren G, Wåhlin N, Sköldenberg E et al. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney. J Urol 2003; 170: 1551– 5 25 Molitierno JM, Scherz HC, Kirsch AJ. Endoscopic Injection of Dextranomer Hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters. J Pediatr Urol 2008; 4: 372– 6 26 Perez-Brayfield M, Kirsch AJ, Hensle TW et al. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol 2004; 172: 1614– 6 27 Cerwinka W, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. J Urol 2007; 178: 1469– 73 28 Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 2006; 176: 1856– 9 29 Puri P, Mohanan N, Menezes M et al. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid. J Urol 2007; 178: 1714– 6 30 Wadie GM, Tirabassi MV, Courtney RA et al. The deflux procedure reduces the incidence of urinary tract infections in patients with vesicoureteral reflux. J Laparoendosc Adv Surg Tech A 2007; 17: 353– 9 31 Läckgren G, Skoldenberg E, Stenberg A. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol 2007; 177: 1124– 8 32 Roihuvuo-Leskinen HM, Koskimaki JE, Tammela TL et al. Urine flow curve shapes in adults with earlier vesicoureteral reflux. Eur Urol 2008; 54: 188– 94 Citing Literature Volume105, Issue9May 2010Pages 1332-1347 ReferencesRelatedInformation